Evidence map›Paper›PMID 37449051›Full record

ArticleOphthalmology science2023

AI-Human Hybrid Workflow Enhances Teleophthalmology for the Detection of Diabetic Retinopathy.

Eliot R Dow, Nergis C Khan, Karen M Chen, Kapil Mishra, Chandrashan Perera, Ramsudha Narala, Marina Basina, Jimmy Dang, Michael Kim, Marcie Levine and 9 more

Open access · goldAbstract read
In one paragraph

Article in Ophthalmology science, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed, 2 pooled it
6.4field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 2 syntheses or guidelines pooled it, 28 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. AI-driven multimodal retinal imaging for early detection and risk stratification of vascular and neurodegenerative diseases.Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie · 2026
    Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 3 institutions in 1 country.

Eliot R DowByers Eye Institute at Stanford, Stanford University School of Medicine, Palo Alto, California.
Nergis C KhanByers Eye Institute at Stanford, Stanford University School of Medicine, Palo Alto, California.
Karen M ChenByers Eye Institute at Stanford, Stanford University School of Medicine, Palo Alto, California.
Kapil MishraByers Eye Institute at Stanford, Stanford University School of Medicine, Palo Alto, California.
Chandrashan PereraByers Eye Institute at Stanford, Stanford University School of Medicine, Palo Alto, California.
Ramsudha NaralaByers Eye Institute at Stanford, Stanford University School of Medicine, Palo Alto, California.
Marina BasinaStanford Healthcare, Stanford University, Palo Alto, California.
Jimmy DangStanford Healthcare, Stanford University, Palo Alto, California.
Michael KimStanford Healthcare, Stanford University, Palo Alto, California.
Marcie LevineStanford Healthcare, Stanford University, Palo Alto, California.
Anuradha PhadkeStanford Healthcare, Stanford University, Palo Alto, California.
Marilyn TanStanford Healthcare, Stanford University, Palo Alto, California.
Kirsti WengStanford Healthcare, Stanford University, Palo Alto, California.
Diana V DoByers Eye Institute at Stanford, Stanford University School of Medicine, Palo Alto, California.
Darius M MoshfeghiByers Eye Institute at Stanford, Stanford University School of Medicine, Palo Alto, California.
Vinit B MahajanByers Eye Institute at Stanford, Stanford University School of Medicine, Palo Alto, California.
Prithvi MruthyunjayaByers Eye Institute at Stanford, Stanford University School of Medicine, Palo Alto, California.
Theodore LengByers Eye Institute at Stanford, Stanford University School of Medicine, Palo Alto, California.
David MyungByers Eye Institute at Stanford, Stanford University School of Medicine, Palo Alto, California.
Stanford University · USStanford Health Care · USVA Palo Alto Health Care System · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: Detection of diabetic retinopathy (DR) outside of specialized eye care settings is an important means of access to vision-preserving health maintenance. Remote interpretation of fundus photographs acquired in a primary care or other nonophthalmic setting in a store-and-forward manner is a predominant paradigm of teleophthalmology screening programs. Artificial intelligence (AI)-based image interpretation offers an alternative means of DR detection. IDx-DR (Digital Diagnostics Inc) is a Food and Drug Administration-authorized autonomous testing device for DR. We evaluated the diagnostic performance of IDx-DR compared with human-based teleophthalmology over 2 and a half years. Additionally, we evaluated an AI-human hybrid workflow that combines AI-system evaluation with human expert-based assessment for referable cases. Design: Prospective cohort study and retrospective analysis. Participants: Diabetic patients ≥ 18 years old without a prior DR diagnosis or DR examination in the past year presenting for routine DR screening in a primary care clinic. Methods: Macula-centered and optic nerve-centered fundus photographs were evaluated by an AI algorithm followed by consensus-based overreading by retina specialists at the Stanford Ophthalmic Reading Center. Detection of more-than-mild diabetic retinopathy (MTMDR) was compared with in-person examination by a retina specialist. Main Outcome Measures: Sensitivity, specificity, accuracy, positive predictive value, and gradability achieved by the AI algorithm and retina specialists. Results: The AI algorithm had higher sensitivity (95.5% sensitivity; 95% confidence interval [CI], 86.7%-100%) but lower specificity (60.3% specificity; 95% CI, 47.7%-72.9%) for detection of MTMDR compared with remote image interpretation by retina specialists (69.5% sensitivity; 95% CI, 50.7%-88.3%; 96.9% specificity; 95% CI, 93.5%-100%). Gradability of encounters was also lower for the AI algorithm (62.5%) compared with retina specialists (93.1%). A 2-step AI-human hybrid workflow in which the AI algorithm initially rendered an assessment followed by overread by a retina specialist of MTMDR-positive encounters resulted in a sensitivity of 95.5% (95% CI, 86.7%-100%) and a specificity of 98.2% (95% CI, 94.6%-100%). Similarly, a 2-step overread by retina specialists of AI-ungradable encounters improved gradability from 63.5% to 95.6% of encounters. Conclusions: Implementation of an AI-human hybrid teleophthalmology workflow may both decrease reliance on human specialist effort and improve diagnostic accuracy. Financial Disclosures: Proprietary or commercial disclosure may be found after the references.

Indexed as

Artificial intelligenceDeep learningDiabetic retinopathyHuman-in-the-loopTeleophthalmology

Identifiers

PMID37449051
PMCPMC10336195
OpenAlexW4381707706

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.